(Q30998627)

English

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

8 references

25 April 2019

12 September 2019

17 September 2019

2 October 2019

7 November 2019

13 November 2019

30 January 2021

29 April 2021

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology (English)

1 reference

Europe PubMed Central

19 October 2017

Alzheimer's disease

6 references

25 April 2019

12 September 2019

17 September 2019

2 October 2019

7 November 2019

13 November 2019

nerve degeneration

8 references

25 April 2019

12 September 2019

17 September 2019

2 October 2019

7 November 2019

13 November 2019

30 January 2021

29 April 2021

1 reference

12 September 2019

heterocyclic compound

1 reference

17 September 2019

mechanism of action

1 reference

2 October 2019

1 reference

7 November 2019

1 reference

7 November 2019

polycyclic compound

1 reference

13 November 2019

cholinesterase inhibitors

1 reference

30 January 2021

1 reference

29 April 2021

Jeffrey L. Cummings

2

object named as

Jeffrey Cummings

1 reference

Europe PubMed Central

19 October 2017

author name string

Marwan Sabbagh

1

1 reference

Europe PubMed Central

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 February 2011

9 references

Europe PubMed Central

19 October 2017

25 April 2019

12 September 2019

17 September 2019

2 October 2019

7 November 2019

13 November 2019

30 January 2021

29 April 2021

9 references

Europe PubMed Central

19 October 2017

25 April 2019

12 September 2019

17 September 2019

2 October 2019

7 November 2019

13 November 2019

30 January 2021

29 April 2021

11

1 reference

Europe PubMed Central

19 October 2017

21

1 reference

Europe PubMed Central

19 October 2017

copyright license

Creative Commons Attribution 2.0 Generic

8 references

Europe PubMed Central

25 April 2019

Europe PubMed Central

12 September 2019

Europe PubMed Central

17 September 2019

Europe PubMed Central

2 October 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

13 November 2019

Europe PubMed Central

30 January 2021

Europe PubMed Central

29 April 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1471-2377-11-21

0 references

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Positron emission tomography imaging in dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Alzheimer Disease in the US Population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

The cholinergic deficit in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

21 June 2018

Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-21

21 January 2018

Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042005

25 November 2018

Identifiers

10.1186/1471-2377-11-21

1 reference

Europe PubMed Central

19 October 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2377-11-21

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30998627&oldid=1977102030"